Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 4

Long term administration of granulocyte macrophage colony stimulating factor prevents 1-2 dimethylhydrazine induced colon cancer in rats

Uzun süreli granülosit-makrofaj koloni stimulating faktör kullanımı 1-2 DMH ile oluşturulan kolon kanserini sıçanlarda önlemektedir

Pages
383–386
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study indicates that continuous stimulation of immune system by GM-CSF can prevent or delay the appearance and inhibit the development of DMH induced colon cancer in rats.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study is to investigate the effects of long-term immune stimulation on the prevention of 1-2 dimethylhidrazine (DMH) induced colon cancer in rats.
📊
Key Findings & Data:Material and Method: The colon tumours were induced by 1-2 DMH through 18 weeks in all rats.
💡
Conclusion & Impact:Conclusion: Our study indicates that continuous stimulation of immune system by GM-CSF can prevent or delay the appearance and inhibit the development of DMH induced colon cancer in rats.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kolon neoplazmları · Granülosit-makrofaj koloni uyarıcı faktör · 2-Dimetilhidrazin

Abstract

Objective: The aim of the present study is to investigate the effects of long-term immune stimulation on the prevention of 1-2 dimethylhidrazine (DMH) induced colon cancer in rats. Material and Method: The colon tumours were induced by 1-2 DMH through 18 weeks in all rats. Group 1 (20 rats) received saline, 6 µg/kg GM-CSF treatment in group 2 (20 rats) and 12 µg/kg GM-CSF treatment in group 3 (20 rats) began at the same time with DMH injections and continued through 24 weeks. Result: Mean tumour count and volume were significantly lower in GM-CSF treated groups compared to saline treated group (p<0.001). Conclusion: Our study indicates that continuous stimulation of immune system by GM-CSF can prevent or delay the appearance and inhibit the development of DMH induced colon cancer in rats.

Özet

Amaç: Çalışmanın amacı 1-2 dimetilhidrazin (1-2 DMH) ile indüklenen kolon kanserli ratlarda immunostimülasyonun olası koruyucu etkisinin araştırılmasıdır. Gereç ve Yöntem: Planlanan deneyde tüm sıçanlara 18 hafta boyunca 1-2 DMH injeksiyonu ile kolon tümörü oluşumu indüklenmiştir. 1-2 DMH injeksiyonu başlangıcı ile beraber 24. hafta bitimine kadar, birinci gruba (20 sıçan) salin solusyonu, ikinci gruba (20 sıçan) 6 µg/kg GM-CSF, üçüncü gruba (20 sıçan) ise 12 µg/kg GM-CSF uygulanmıştır. Bulgular: Bu deneyde ortalama tümör sayısı ve hacmi, GM-CSF ile tedavi edilmiş sıçanlarda salin verilmiş sıçanlara kıyasla belirgin olarak düşüktür. Sonuç: GM-CSF ile immun sistemin uzun süreli uyarımı ile 1-2 DMH ile indüklenen kolon kanserinin oluşumunun engellenebileceği ve koruma sağlayacağını göstermektedir.

🔖

Cite This Article

DİNÇ, S., ÖZBİRECİKLİ, B., GÜLÇELİK, M. A., ÇAMLIBEL, M., ELİTOK, O., ÜSTÜN, H., ALAGÖL, H. (2005). Long term administration of granulocyte macrophage colony stimulating factor prevents 1-2 dimethylhydrazine induced colon cancer in rats. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 4, 383–386. https://ajindex.com/articles/278370

References (2)

  1. J. Ferlay, F. Bray, P. Pisani and D.M. Parkin.GLOBOCAN 2002:
  2. Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5. version 2.0, lARCPress, Lyon 2004 2. Potter JD. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999; 91:916-32. 3. Kellof GJ, Crowell JA, Steele VE, et al. Progress in cancer chemoprevention. Ann NY Acad Sci 1999; 889: 1-13. 4. Weisbart RH, Kacena A, Schuh A, Golde DW. GM-CSF induces human neutrophils IgA mediated phagositosis by an IgA Fc receptor activation mechanism. Nature 1988; 332:647-8. 5. Lopez AF, Williamson DJ, Gamble JR, et al. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human neutrophils and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78:1220-8. 6. Kushner BH, Cheung NK. GM-CSF enhances 3F8 monoclonal antibody dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 1989; 73:1936-41. 7. Grabstein KH, Urdal DL, Tushinski RJ et al. Induction of macrophage tumoricidal activity by granulocyte macrophage colony stimulating factor. Science 1986; 232:506-8. 8. Djeu JY, Widen R, Blanchard DK. Susceptibility of mo- nocytes to lymphokine-activated killer cell lysis: effect of granulocyte-macrophage colony stimulating factor and interleukin-3. Blood 1989; 73:1264-71 9. Wing EJ, Magee DM, Whiteside TL, Kaplan SS, Shadduck RK. Recombinant human granulocyte-macrophage colony-stimulating factor enhances monocytes cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.Blood 1989; 73:643-6. 10. Nigro ND, Bhadrachari N, Chomchai C. A rat model for studying colonic cancer. Dis Colon Rec 1973; 16:438-41. 11. Maley MAL, House AK. The immune status of the rat with carcinoma of the bowel. Br J Exp Path 1983; 64:245-51. 12. Wynder EL, Shigematsu T. Environmental factors of cancer of the colon and rectum. Cancer 1967; 20:1520-61. 13. Spjut HJ, Noall MW. Experimental inductions of tumors of the large bowel of rats are view of the experience with 3-2 dimethyl-4-aminobiphenyl. Cancer 1971; 28:29-37. 14. Hirose M, Takahashi S, Ogawa K, et al. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds rats. Cancer lett 1999; 143:173-8. 15. Steele G, Sjoegren HO. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth. Surgery 1977; 82164-9. 16. Bast RC, Zbar B, Borsos T, et al. BCG and cancer. N Eng J Med 1974